These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 19798110

  • 1. Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes.
    Anvari M, Khalilzadeh O, Esteghamati A, Esfahani SA, Rashidi A, Etemadi A, Mahmoudi M, Amirzargar AA.
    Eye (Lond); 2010 Jun; 24(6):1058-63. PubMed ID: 19798110
    [Abstract] [Full Text] [Related]

  • 2. Graves' disease and gene polymorphism of TNF-α, IL-2, IL-6, IL-12, and IFN-γ.
    Anvari M, Khalilzadeh O, Esteghamati A, Momen-Heravi F, Mahmoudi M, Esfahani SA, Rashidi A, Amirzargar A.
    Endocrine; 2010 Apr; 37(2):344-8. PubMed ID: 20960273
    [Abstract] [Full Text] [Related]

  • 3. Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist.
    Khalilzadeh O, Anvari M, Esteghamati A, Mahmoudi M, Tahvildari M, Rashidi A, Khosravi F, Amirzargar A.
    Clin Exp Ophthalmol; 2009 Aug; 37(6):614-9. PubMed ID: 19702713
    [Abstract] [Full Text] [Related]

  • 4. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
    Du J, Wang X, Tan G, Wei W, Zhou F, Liang Z, Li H, Yu H.
    J Mol Med (Berl); 2021 Oct; 99(10):1487-1495. PubMed ID: 34287665
    [Abstract] [Full Text] [Related]

  • 5. TNFSF15 Polymorphisms are Associated with Graves' Disease and Graves' Ophthalmopathy in a Han Chinese Population.
    Zhang M, Liu S, Xu J, Lv S, Fan Y, Zhang Y, Zhang Y, Wu Y, Su Y, Yu H, Song S, He J, Li H.
    Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260
    [Abstract] [Full Text] [Related]

  • 6. The VDR gene confers a genetic predisposition to Graves' disease and Graves' ophthalmopathy in the Southwest Chinese Han population.
    Zhou F, Liang Z, Wang X, Tan G, Wei W, Zheng G, Ma X, Tian D, Li H, Yu H.
    Gene; 2021 Aug 15; 793():145750. PubMed ID: 34077777
    [Abstract] [Full Text] [Related]

  • 7. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
    Esteghamati A, Khalilzadeh O, Mobarra Z, Anvari M, Tahvildari M, Amiri HM, Rashidi A, Solgi G, Parivar K, Nikbin B, Amirzargar A.
    Eur J Intern Med; 2009 Jul 15; 20(4):424-8. PubMed ID: 19524188
    [Abstract] [Full Text] [Related]

  • 8. Lack of association of interleukin-18 gene polymorphisms with susceptibility of Japanese populations to Graves' disease or Graves' ophthalmopathy.
    Mukai T, Hiromatsu Y, Ichimura M, Fukutani T, Kaku H, Miyake I, Shoji S, Koda Y, Bednarczuk T.
    Thyroid; 2006 Mar 15; 16(3):243-8. PubMed ID: 16571086
    [Abstract] [Full Text] [Related]

  • 9. Association analysis of cytokine polymorphisms and plasma level in Northern Chinese Han patients with paroxysmal nocturnal hemoglobinuria.
    Wang SY, Yang XJ, Yang SS, Wang W, Tian YY, Cao FL, Zhou J.
    Chin Med J (Engl); 2012 May 15; 125(9):1576-80. PubMed ID: 22800824
    [Abstract] [Full Text] [Related]

  • 10. The association of interleukin-1alpha and interleukin-1beta polymorphisms with the risk of Graves' disease in a case-control study and meta-analysis.
    Liu N, Li X, Liu C, Zhao Y, Cui B, Ning G.
    Hum Immunol; 2010 Apr 15; 71(4):397-401. PubMed ID: 20116409
    [Abstract] [Full Text] [Related]

  • 11. Association of PARP-1, NF-κB, NF-κBIA and IL-6, IL-1β and TNF-α with Graves Disease and Graves Ophthalmopathy.
    Niyazoglu M, Baykara O, Koc A, Aydoğdu P, Onaran I, Dellal FD, Tasan E, Sultuybek GK.
    Gene; 2014 Sep 01; 547(2):226-32. PubMed ID: 24956560
    [Abstract] [Full Text] [Related]

  • 12. Role of cytokine gene (interferon-γ, transforming growth factor-β1, tumor necrosis factor-α, interleukin-6, and interleukin-10) polymorphisms in the risk of oral precancerous lesions in Taiwanese.
    Hsu HJ, Yang YH, Shieh TY, Chen CH, Kao YH, Yang CF, Ko EC.
    Kaohsiung J Med Sci; 2014 Nov 01; 30(11):551-8. PubMed ID: 25458044
    [Abstract] [Full Text] [Related]

  • 13. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children.
    Chong KK, Chiang SW, Wong GW, Tam PO, Ng TK, Hu YJ, Yam GH, Lam DS, Pang CP.
    Invest Ophthalmol Vis Sci; 2008 Jun 01; 49(6):2409-15. PubMed ID: 18296657
    [Abstract] [Full Text] [Related]

  • 14. The Role of FOXP3 Polymorphisms in Graves' Disease with or without Ophthalmopathy in a Turkish Population.
    Yaylacıoğlu Tuncay F, Serbest Ceylanoğlu K, Güntekin Ergün S, Ergün G, Konuk O.
    Turk J Ophthalmol; 2024 Apr 19; 54(2):69-75. PubMed ID: 38645270
    [Abstract] [Full Text] [Related]

  • 15. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy.
    Khalilzadeh O, Mojazi Amiri H, Tahvildari M, Anvari M, Esteghamati A, Mobarra Z, Tehranchinia Z, Rashidi A, Amirzargar A.
    Arch Dermatol Res; 2009 Oct 19; 301(10):719-23. PubMed ID: 19037649
    [Abstract] [Full Text] [Related]

  • 16. Role of cytokine gene (IFN-γ, TNF-α, TGF-β1, IL-6, and IL-10) polymorphisms in pathogenesis of acute rheumatic fever in Turkish children.
    Col-Araz N, Pehlivan S, Baspinar O, Oguzkan-Balci S, Sever T, Balat A.
    Eur J Pediatr; 2012 Jul 19; 171(7):1103-8. PubMed ID: 22350281
    [Abstract] [Full Text] [Related]

  • 17. IFN-γ and TNF-α Gene Polymorphisms in Multiple Sclerosis Patients in Northwest Iran.
    Asgharzadeh M, Najafi-Ghalehlou N, Poor BM, Asgharzadeh V, Pourostadi M, Vegari A, Kafil HS, Fadaee M, Farhoudi M, Rashedi J.
    Endocr Metab Immune Disord Drug Targets; 2021 Jul 19; 21(3):520-525. PubMed ID: 32368988
    [Abstract] [Full Text] [Related]

  • 18. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity.
    Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y.
    J Clin Endocrinol Metab; 2008 Mar 19; 93(3):1077-81. PubMed ID: 18073300
    [Abstract] [Full Text] [Related]

  • 19. The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients.
    Han SZ, Zhang SH, Li R, Zhang WY, Li Y.
    Int J Immunogenet; 2006 Aug 19; 33(4):281-7. PubMed ID: 16893393
    [Abstract] [Full Text] [Related]

  • 20. Cytokine promoter polymorphisms in Taiwanese patients with Graves' disease.
    Shiau MY, Huang CN, Yang TP, Hwang YC, Tsai KJ, Chi CJ, Chang YH.
    Clin Biochem; 2007 Feb 19; 40(3-4):213-7. PubMed ID: 17208210
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.